Glossopharyngeal neuralgia is a relatively rare but exceptionally distressing pain condition associated with damage to or irritation of the ninth cranial nerve (the glossopharyngeal nerve).
Although it often remains poorly recognized, its symptoms can be dramatic and may occasionally lead to syncope or cardiac arrhythmias.
What Is Glossopharyngeal Neuralgia?
It is a pain syndrome characterized by paroxysms of severe, piercing pain at the base of the tongue, the posterior pharyngeal wall, the palatine tonsils, the Eustachian tube opening, and the ear.
Pain attacks most commonly occur unilaterally, last from a few seconds to approximately two minutes, and have a typically neuralgic character: sudden, electric, and extremely intense.
Pain is frequently triggered by everyday activities such as:
- swallowing, chewing, yawning, coughing, or speaking,
- and even touch in so-called trigger zones (e.g., the tonsillar area, the posterior tongue).
A Brief History
The first case was described in 1910 in JAMA. The author was American neurologist Theodore Herman Weisenburg, who described pain occurring in a patient with a cerebellopontine angle tumor.
The term "glossopharyngeal neuralgia" was introduced by Wilfred Harris in 1921. It was Harris who noted that pain attacks could be provoked by speaking, swallowing, or yawning.
In later years, the association of this neuralgia with cardiovascular symptoms such as bradycardia and syncope was also discovered.
Epidemiology
- The condition occurs approximately 100 times less frequently than trigeminal neuralgia.
- Incidence is estimated at approximately 0.7 per 100,000 persons per year.
- It most commonly affects people over 50, although it can appear at any age.
- Some studies show a slight female predominance, and pain more often affects one side, more frequently the left.
- In a small group of patients, bilateral forms occur.
Most Characteristic Symptoms
- Paroxysmal, piercing pain at the base of the tongue, in the throat, ear, or angle of the jaw,
- Brief, violent pain attacks (seconds to 2 minutes),
- Triggers: swallowing, chewing, speaking, coughing, sneezing, touch near the tonsils,
- Accompanying symptoms: cardiac arrhythmias, syncope, drops in blood pressure (Morgagni-Adams-Stokes attacks), hoarseness, dizziness.
Due to severe pain during eating, patients often avoid meals and may lose weight.
Classification
According to the International Classification of Orofacial Pain (ICOP), glossopharyngeal neuralgia may also involve branches of the vagus nerve (X).
Two main types are distinguished:
- Classical (idiopathic) form — no visible cause, often due to vascular compression of the nerve.
- Symptomatic (secondary) form — resulting from another condition, such as a skull base tumor, inflammation, vascular malformation, or Eagle's syndrome (elongated styloid process).
Diagnosis
Diagnosis is based primarily on a thorough history and characterization of the pain.
Imaging studies help exclude other causes:
- MRI/MRA of the head and neck — detects nerve compression, vascular changes, tumors, or demyelination,
- 3D angiography — assesses the relationship of vessels to the nerve root,
- ECG — when cardiac arrhythmias during pain attacks are suspected.
In unclear cases, diagnostic lidocaine blocks in the tonsillar region are performed. If pain resolves, this confirms the diagnosis.
Treatment
1. Pharmacological Treatment
First-line therapy consists of anticonvulsants that stabilize neuronal membranes: carbamazepine (drug of choice), gabapentin, pregabalin.
In some cases, baclofen or SSRIs are also used.
Treatment begins with low doses, gradually increased until effectiveness is achieved. In most patients, improvement occurs within 1–2 months.
2. Nerve Blocks
When oral treatment is ineffective:
- Local blocks with lidocaine or bupivacaine,
- Less commonly, neurolytic blocks (e.g., alcohol or phenol) in severe cases.
The procedure is performed through the oral cavity (palatine arch area) or via an external approach (mastoid process region).
Blocks often provide immediate relief but require experience due to the risk of damage to adjacent structures.
3. Surgical Treatment
If pharmacotherapy fails, neurosurgical interventions are possible:
- Microvascular decompression of nerve IX — removal of vascular compression on the nerve; the most effective treatment method,
- Rhizotomy (nerve sectioning) — used when decompression is not feasible,
- Cause-directed procedures — e.g., tumor removal, shortening of the styloid process (stylectomy), aneurysm embolization, decompression in Arnold-Chiari syndrome.
In cases of pain attacks accompanied by syncope (MAS attacks), pacemaker implantation may be the only effective treatment.
When Throat Pain Causes Fainting
In some patients, pain attacks can cause abrupt cardiac slowing and blood pressure drops resulting in syncope. This occurs because the glossopharyngeal nerve is functionally connected to the vagus nerve, which controls cardiac function. This symptom complex is termed vago-glossopharyngeal neuralgia.
Natalia — since 2014 I've been living with trigeminal nerve pain. I write in plain language, based on reliable sources and personal experience. Read my story →
Frequently Asked Questions
What is trigeminal neuralgia?
Trigeminal neuralgia is a chronic facial pain condition. It manifests as sudden, severe, usually one-sided pain attacks — often described as an electric shock. A single attack typically lasts from a few seconds to about two minutes.
How does carbamazepine work for trigeminal neuralgia?
Carbamazepine is the first-line medication for trigeminal neuralgia. In a large proportion of patients, it provides effective pain control. It requires gradual dose adjustment and medical supervision.
What is the difference between gabapentin and pregabalin?
Both are anticonvulsant medications used for neuropathic pain. They differ in absorption and dosing characteristics. The choice and dosage should be determined by a physician.
What is neurovascular conflict (vascular compression)?
This is the most common cause of classical trigeminal neuralgia — a blood vessel compresses the nerve root at the base of the brain, damaging its myelin sheath and triggering pain.
What is microvascular decompression (MVD)?
MVD is a neurosurgical procedure in which the vessel compressing the trigeminal nerve is moved away. In eligible patients, it provides the most durable pain relief. The decision is made by the treating team.
Related Articles
Gabapentin and Pregabalin for Trigeminal Neuralgia
Gabapentin and pregabalin are antiepileptic drugs commonly used to treat trigeminal neuralgia and other types of neuropathic pain. They work by calming ove…
Carbamazepine for Trigeminal Neuralgia: Benefits, Risks, and Why It Works
Some time ago I wrote posts about gabapentin and pregabalin, so the time has come for carbamazepine. For me, it was a medication that became a true "game o…
Diagnosing Trigeminal Neuralgia — MRI, Neurophysiology, and Differential Diagnosis
In the diagnosis of trigeminal neuralgia, precise neuroimaging (MRI) and electrophysiological studies are of key importance.
Track your attacks, triggers, and medications — and show your doctor a clear picture of your condition.